Results 181 to 190 of about 45,533 (284)

Differential Gene Expression in Differentiated Human Neuroblastoma SH-SY5Y Cells in Response to a Cocktail of Monoamine Oxidase Inhibitors. [PDF]

Int J Mol Sci
Niraula P, Page RA, Palmer BR, Truman P.
europepmc   +1 more source

Improvement in Quality of Life and Non‐Motor Symptoms Associated With OFF Episodes in People With Parkinson's Disease Treated With Inhaled Levodopa

European Journal of Neurology, Volume 33, Issue 8, August 2026.
The open prospective multicenter INLEVO‐LIFE PD study showed in 40 patients with Parkinson's disease after 3 months of use of inhaled levodopa for OFF episodes an improvement in health‐related quality of life (primary endpoint) and also, as highlighted data, an effect of at least 90 min after its administration not only on motor status (UPDRS‐III) but ...
Diego Santos García, María Cerdán Sánchez, Rosa Yáñez Baña, Iria Cabo, Maria Icíar Cimas Hernando   +4 more
wiley   +1 more source

Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson's Disease: An Update. [PDF]

Pharmaceuticals (Basel)
Ribeiro LV, Massuda LE, Gontijo VS, Viegas C.   +3 more
europepmc   +1 more source

Validation of an ELISA assay for measurement of the metabolite of serotonin, 5‐hydroxyindole acetic acid (5‐HIAA), in canine urine

Journal of Small Animal Practice, Volume 67, Issue 8, Page 680-685, August 2026.
Objectives Serotonin (5‐hydroxytryptophan), implicated in a number of canine diseases, has a very short half‐life in the serum. Urine concentration of its breakdown product 5‐hydroxyindole acetic acid after an 8 hour fast is a more reliable measure of circulating serotonin in humans.
D. Castillo, A. Swallow, T. Williams, P. Watson   +3 more
wiley   +1 more source

Synthesis and biological evaluation of <i>N</i>/<i>O</i>-propargylated diarylpyrimidines as dual inhibitors of acetylcholinesterase and monoamine oxidase. [PDF]

RSC Adv
Kumar N, Jangid K, Kumar V, Dwivedi AR, Kumar V, Devi B, Arora T, Parkash J, Kumar V.   +8 more
europepmc   +1 more source

Catecholamines Activate a Tumour Progression Program in Differentiated Tumour Hepatocytes

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims The sympathetic nervous system is involved in the progression and aggressiveness of several cancers, including hepatocellular carcinoma (HCC). However, the specific effects of sympathetic innervation and catecholamines on tumour hepatocyte behaviour remain poorly understood.
Elise Lelou, Claudine Rauch, Hélène Dubois‐Pot‐Schneider, Marjorie Dufresne, Abolfazl Zekri Yazdi, Maelle Guillout, Luis Cano, Lise Desquilles, Nicolas Nesseler, Marc Bourgeois, Claude Bendavid, Julie Massart, Orlando Musso, Anne Corlu, Caroline Aninat   +14 more
wiley   +1 more source

Evolutionary and Functional Analysis of Monoamine Oxidase F: A Novel Member of the Monoamine Oxidase Gene Family. [PDF]

Genome Biol Evol
Merello Oyarzún G, Olivares-Costa M, Basile L, Pástor TP, Mendoza-Soto P, Padilla-Santiago L, Mardones GA, Binda C, Opazo JC.   +8 more
europepmc   +1 more source

Rhizobacteria‐Induced Systemic Priming Against Fungal Pathogens Involves Hydroxycinnamic Acid Amides

Plant, Cell &Environment, Volume 49, Issue 8, Page 4907-4921, August 2026.
ABSTRACT The rhizosphere, a narrow region of soil surrounding roots, contains diverse microorganisms with a composition that is distinct from the surrounding soil. Some rhizosphere bacteria can trigger a heightened state of immunity in the whole plant, termed Induced Systemic Resistance (ISR).
Mackenzie Eli William Loranger, Wolfgang Moeder, Hyunsuh Lee, David K. Liscombe, Eric Déziel, Keiko Yoshioka   +5 more
wiley   +1 more source

Correction to "Monoamine Oxidase-A Is a Novel Driver of Stress-Induced Premature Senescence Through Inhibition of Parkin-Mediated Mitophagy". [PDF]

Aging Cell
europepmc   +1 more source

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer's Disease. [PDF]

Molecules
Asim A, Jastrzębski MK, Kaczor AA.
europepmc   +1 more source